Appeal No. 2000-1682 Page 10 Application No. 08/845,503 the determination of the depth of cutting. [examiner’s answer at page 6]. Appellant’s specification discloses that a series of microcutters having blades of different length along with ink markers are used to measure the thickness of the layers of skin at a specific delivery site for each patient (specification at page 8). While Gerstel does disclose that the Gerstel delivery device is designed to penetrate the stratum corneum for the administration of a drug without contacting the nerves for achieving an essentially painless drug administration, Gerstel does not disclose that the device is designed for a particular patient and a particular site on the patient to ensure that the device penetrates the stratum corneum without contacting the body of nerves. In view of the foregoing, we will not sustain the examiner’s rejection of method claim 4 or method claims 5, 10 and 11 dependent therefrom. We turn next to the examiner’s rejection of claims 1 through 5 and 10 through 11 under 35 U.S.C. § 102(b) as being anticipated by Ganderton. In support of this rejection, the examiner states:Page: Previous 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 NextLast modified: November 3, 2007